Practice Management News

The American Red Cross has declared, for the first time, a national blood crisis.

Both at the end of the year and in the beginning of the following year, many physicians focus on charitable planning.

Acute generalized exanthematous pustulosis is usually triggered by new antimicrobials and is often improved with the discontinuation of the causing drug, according to a study.

The FDA approved many new drugs and technologies over the past year, and in the dermatology world those approvals included treatments for a multitude of conditions.

Australian, American, Canadian and British panels that developed clinical practice recommendations most often consisted of white men and excluded historically underrepresented women, researchers reported in The Lancet.

A new study on Choosing Wisely showed the campaign’s recommendations had strengths and opportunities for improvement, one of the study’s authors said.

The No Surprises Act, which officially took effect Jan. 1 as a way to protect patients from unexpected medical bills, already faces several lawsuits from health care organizations.

The rollout of three COVID-19 vaccines has begun to ease the burden the virus has on U.S. hospitals and death rates; however, a small number of people have experienced cutaneous reactions to the vaccine, including those with facial fillers.

Physicians interested in estate or asset protection planning inevitably inquire about the use of trusts. Certainly, trusts can play significant roles in many physicians’ estate and/or asset protection planning.

Increasing asset limits placed on low-income Medicare beneficiaries seeking Medicaid supplemental coverage, which in many states have remained unchanged for 30 years, could increase eligibility by as much as 7.5%, according to researchers.